MIMETAS enables scientists to develop better predictive human tissue and disease models with organ-on-a-chip technology. Our vision is to create the simplest device for the most complex 3D biology. The OrganoPlate® platform allows perfused 3D cell culture, membrane free co-culture and culture of tubules and vessels in a throughput never seen before.
Curi Bio provides a seamless, bioengineered integration of human stem cells, systems, and data to accelerate the discovery of new medicines. Curi’s suite of human stem cell-based products and services enable scientists to build mature and predictive human iPSC-derived tissues—with a focus on cardiac, skeletal muscle, and neuromuscular models—for the discovery, safety testing, and efficacy testing of new therapeutics. Curi seeks to de-risk and expedite the development of new drugs by decreasing the industry’s dependence on animal models, which often fail to translate to humans. By providing researchers human-relevant preclinical data at the earliest stages of the development pipeline, Curi aims to dramatically accelerate the discovery and development of safer, more effective medicines.
Obatala Sciences, Inc is a biotechnology company that offers brain power and research tools to advance the fields of obesity, diabetes, related metabolic disorders and cancers, and regenerative medicine. Our mission is to drive diversity in research and impact the future of regenerative medicine. To advance this mission, we manufacture adult stem/stromal cells, unique 3D cell culture tools, and we are progressing an FDA-approved protocol for testing a stem cell based therapy for wound healing applications in humans.
Toyo Gosei Co., Ltd offers a novel type of micro-patterned multi-well 3D culture plate Cell-able®. The unique culture surface makes it possible to form multiple spheroids with uniform sizes attached to the culture surface just by seeding your cells. (In case of 96-well plate, approximately 800 spheroids are formed at once in each well.) The cell-able plate can help to achieve high-throughput and highaccuracy assay with 3D culture because of the adhesiveness of multiple spheroids to the surface, and therefore the plate is suitable for automation assay as well. We are sure that the Cell-able® plate can accelerate your drug development process and minimize your research cost. Toyo Gosei Co., Ltd is a world-leading company in a field of photosensitive materials, and the Cell-able® plate was developed by taking advantage of its strength.